Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre studyKim Linton, Julie M. Vose, Jacob Haaber Christensen et al.|The Lancet Haematology|2024Cited by 134
Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion CohortKim Linton, Catherine Thiéblemont, Wojciech Jurczak et al.|Blood|2023Cited by 38
A hexamerization-enhanced, Fc-silenced agonistic CD27 antibody amplifies T-cell effector functions as single agent and in combination with PD-1 blockadeIşıl Altıntaş, Uğur Şahin|Scientific Reports|2025Cited by 0